NOVOGENE revenue for the last year amounted to 2.00 B CNY, the most of which — 952.58 M CNY — came from its highest performing source at the moment, Sequencing Platform Service, the year earlier bringing 835.24 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought NOVOGENE 1.02 B CNY, and the year before that — 1.12 B CNY.